FNCH
Finch Therapeutics Group, Inc.
Biological Products, (No Diagnostic Substances)OTC<br>Emerging growth company
Total Trades
6
Buys
1
Sells
5
Largest Trade
$15K–$50K
Insiders
4
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
3
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| SMISEK JEFFERY A | Director | SELL | $15K–$50K | 8K | $2.58 | Mar 29, 2024 |
| SMISEK JEFFERY A | Director | SELL | $1K–$15K | 1K | $3.64 | Nov 27, 2023 |
| Graf Susan E | Director | BUY | $1K–$15K | 5K | $0.27 | Jun 9, 2023 |
| Blaustein Marc | COO | SELL | $1K–$15K | 5K | $0.38 | Feb 23, 2023 |
| Blaustein Marc | COO | SELL | $1K–$15K | 4K | $1.39 | Oct 25, 2022 |
| Vittiglio Joseph | Chief Business & L… | SELL | $1K–$15K | 4K | $1.39 | Oct 25, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Sep 30, 2023 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 36K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Dec 13, 2023
10.0%
160K shares
SC 13G · Feb 14, 2022
0.0%
0 shares
SC 13G · Feb 14, 2022
7.4%
3.5M shares